AAAAAA

   
Results: 1-10 |
Results: 10
Elective removal of an intramyocardial bullet
Authors: Poston, RS Sloane, RW Morgan, BR Smith, DC Smithson, JB Hickey, MS
Citation: Rs. Poston et al., Elective removal of an intramyocardial bullet, SOUTH MED J, 94(5), 2001, pp. 464-466
Optimization of ex vivo pressure mediated delivery of antisense oligodeoxynucleotides to ICAM-1 reduces reperfusion injury in rat cardiac allografts
Authors: Feeley, BT Poston, RS Park, AK Ennen, MP Hoyt, EG Vriens, PWHE Robbins, RC
Citation: Bt. Feeley et al., Optimization of ex vivo pressure mediated delivery of antisense oligodeoxynucleotides to ICAM-1 reduces reperfusion injury in rat cardiac allografts, TRANSPLANT, 69(6), 2000, pp. 1067-1074
Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients
Authors: Poston, RS Robbins, RC Chan, B Simms, P Presta, L Jardieu, P Morris, RE
Citation: Rs. Poston et al., Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients, TRANSPLANT, 69(10), 2000, pp. 2005-2013
Ex vivo antisense oligonucleotides to proliferating cell nuclear antigen and Cdc2 kinase inhibit graft coronary artery disease
Authors: Miniati, DN Hoyt, EG Feeley, BT Poston, RS Robbins, RC
Citation: Dn. Miniati et al., Ex vivo antisense oligonucleotides to proliferating cell nuclear antigen and Cdc2 kinase inhibit graft coronary artery disease, CIRCULATION, 102(19), 2000, pp. 237-242
Effect of low molecular weight heparin on graft vascular disease in the rat cardiac allograft model
Authors: Teranishi, K Poston, RS Reitz, BA Robbins, RC
Citation: K. Teranishi et al., Effect of low molecular weight heparin on graft vascular disease in the rat cardiac allograft model, TRANSPLAN P, 31(1-2), 1999, pp. 103-105
Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method
Authors: Poston, RS Mann, MJ Hoyt, EG Ennen, M Dzau, VJ Robbins, RC
Citation: Rs. Poston et al., Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method, TRANSPLANT, 68(6), 1999, pp. 825-832
Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues
Authors: Mann, MJ Gibbons, GH Hutchinson, H Poston, RS Hoyt, EG Robbins, RC Dzau, VJ
Citation: Mj. Mann et al., Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues, P NAS US, 96(11), 1999, pp. 6411-6416
ICAM-1 affects reperfusion injury and graft function after cardiac transplantation
Authors: Poston, RS Ing, DJ Ennen, MP Hoyt, EG Robbins, RC
Citation: Rs. Poston et al., ICAM-1 affects reperfusion injury and graft function after cardiac transplantation, J SURG RES, 87(1), 1999, pp. 25-31
Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model
Authors: Poston, RS Billingham, M Hoyt, EG Pollard, J Shorthouse, R Morris, RE Robbins, RC
Citation: Rs. Poston et al., Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model, CIRCULATION, 100(1), 1999, pp. 67-74
Pressure delivery of AS-ICAM-1 ODN with LFA-1 mAb reduces reperfusion injury in cardiac allografts
Authors: Feeley, BT Park, AK Alexopoulos, S Hoyt, EG Ennen, MP Poston, RS Robbins, RC
Citation: Bt. Feeley et al., Pressure delivery of AS-ICAM-1 ODN with LFA-1 mAb reduces reperfusion injury in cardiac allografts, ANN THORAC, 68(1), 1999, pp. 119-124
Risultati: 1-10 |